Niv

NIV researchers identify B.1.1.28.2 variant of COVID-19: What we know thus far

The new variant was found to induce body weight loss and caused viral replication in the respiratory track, lung lesions in Syrian hamsters

Covaxin neutralises double mutant COVID-19 strain, claims ICMR; 'data on Indian variant in a week,' says Bharat Biotech MD

Bharat Biotech's Covaxin has received Emergency Use Authorizations (EUAs) for COVID-19 treatment in India and in several countries across the globe with another 60 in the process

Covaxin phase 2 data shows vaccine safe, induces immune response, says Lancet study

The authors of the study noted that the phase 2 results did not assess the efficacy of the vaccine codenamed BBV152

Biological E starts Phase I/II trial, Bharat Bio to begin Phase III trials for COVID-19 vaccine candidates

Both the vaccines candidates will be administered in two doses via intramuscular injections 28 days apart.

Covaxin, Bharat Biotech's COVID-19 vaccine candidate, gets DCGI nod for Phase 3 trials

The phase 3 trials will be conducted in 19 sites across 10 states, including in cities such as Delhi, Mumbai, Patna and Lucknow and would seek to enroll 28,500 volunteers aged 18 years and above.

AIIMS panel gives nod to begin human clinical trial of COVID-19 vaccine Covaxin from 20 July

Covaxin, Bharat Biotech's COVID-19 vaccine candidate, has been developed in collaboration with the ICMR and NIV

Coronavirus Updates: Centre postpones JEE, NEET to September due to COVID-19 pandemic; Pakistan foreign minister tests positive

Coronavirus Updates: Union HRD minister Ramesh Pokhriyal on Friday announced that the JEE and NEET exams have been postponed to September in view of the coronavirus pandemic.

Bharat Biotech has passed mandated protocols, animal testing and is now in clinical development of Covid vaccine, Dr Krishna Ella tells Firstpost

Hyderabad-based Bharat Biotech, one of seven Indian companies involved in the indigenous production of a vaccine for the novel coronavirus, received the green signal from the Central Drugs Standard Control Organisation (CDSCO) to begin human trials of 'Covaxin' last week.

India's first COVID-19 vaccine, COVAXIN, by Bharat Biotech gets DCGI nod for human clinical trials

The Phase I and Phase II clinical trials of the vaccine for SARS-CoV-2, approved after pre-clinical studies demonstrated safety and immune response, would start across the country next month.

Delhi Customs officials seize PPE kits, sanitisers and lakhs of masks; consignments were being smuggled to US, UAE and Europe

Large quantities of sanitiser, PPE kits, masks and its raw materials being sent abroad illegally have been seized by customs officials at the cargo terminal in New Delhi, officials said